GlassScriptPhysician profile
James Rabaria Furr
NPI 1326482159
$5,800.16
in general payments reported to CMS, 2019-2025
17 companies · $1,695 in 2025
The $1,695 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $583 · 2021: $583 · 2022: $647 · 2023: $566 · 2024: $1,483 · 2025: $1,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,844 · Consulting Fee: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,844.47 |
| Consulting Fee | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,133.89 | 2021-2025 | Ams 700, General - Erectile Dysfunction, Tactra |
| Coloplast Corp | $1,826.06 | 2019-2025 | Titan |
| Antares Pharma, INC. | $208.05 | 2023-2025 | Xyosted, Tlando |
| Clarus Therapeutics INC. | $106.42 | 2020 | |
| Medtronic, INC. | $103.94 | 2022-2024 | Interstim |
| Uromedica, Incorporated | $95.58 | 2019 | |
| Endo USA, INC. | $71.69 | 2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $55.16 | 2023-2024 | Xiaflex, Aveed |
| Astellas Pharma US INC | $33.67 | 2020 | |
| Sumitomo Pharma America, INC. | $31.29 | 2024-2025 | Gemtesa |
| Innovation Technologies INC | $24.24 | 2025 | Irrisept |
| Biotissue Holdings INC. | $23.17 | 2025 | |
| Davol INC. | $20.57 | 2025 | |
| Laborie Medical Technologies Corp. | $20.16 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Halozyme INC | $16.34 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.13 | 2021 | |
| Steris Corporation | $14.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Furr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.